US Congress Senate Bill 892 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on April 7 2017 - 25% progression, died in committee
Action: 2017-04-07 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.

Opioid Addiction Prevention Act of 2017

Sen. Kirsten Gillibrand [D-NY]

Sen. John McCain [R-AZ]

Sen. Joe Manchin [D-WV]

Date	Chamber	Action
2017-04-07	Senate	Read twice and referred to the Committee on the Judiciary.

HB3964 (Related) 2017-10-16 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HB4408 (Same As) 2017-12-13 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HB4482 (Related) 2018-01-09 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/892/all-info
Text	https://www.congress.gov/115/bills/s892/BILLS-115s892is.pdf